Nimit Ghatalia - Aarey Drugs Executive Director
| AAREYDRUGS | 35.74 0.94 2.56% |
Director
Nimit Ghatalia is Executive Director of Aarey Drugs Pharmaceuticals
| Age | 29 |
| Address | 107, Sahakar Bhavan, Mumbai, India, 400009 |
| Phone | 91 22 6287 2900 |
| Web | https://www.aareydrugs.com |
Aarey Drugs Management Efficiency
The company has return on total asset (ROA) of 0.0108 % which means that it generated a profit of $0.0108 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0472 %, meaning that it generated $0.0472 on every $100 dollars invested by stockholders. Aarey Drugs' management efficiency ratios could be used to measure how well Aarey Drugs manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Aarey Drugs' Total Assets are relatively stable compared to the past year. As of 03/26/2025, Non Current Assets Total is likely to grow to about 250 M, while Other Current Assets are likely to drop slightly above 137.5 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Soundararajan Venkateswaran | LLOYDS METALS AND | 55 | |
| Balasubramanian Prabhakaran | LLOYDS METALS AND | 52 | |
| Laxmi Sharma | Zota Health Care | 50 | |
| Arun Vora | Ratnamani Metals Tubes | N/A | |
| Madhur Gupta | LLOYDS METALS AND | 34 | |
| Abhiram Tayal | Hisar Metal Industries | 72 | |
| Himanshu Zota | Zota Health Care | 51 | |
| Sanjay Agarwal | Shyam Metalics and | 49 | |
| Jayantilal BCom | Ratnamani Metals Tubes | 67 | |
| Moxesh Zota | Zota Health Care | 35 | |
| Karan Tayal | Hisar Metal Industries | 45 | |
| Shantilal Sanghvi | Ratnamani Metals Tubes | 61 | |
| Viren Zota | Zota Health Care | 41 | |
| Sheetij Agarwal | Shyam Metalics and | N/A | |
| Rajesh BCom | LLOYDS METALS AND | 61 | |
| Manukant Zota | Zota Health Care | 73 | |
| Kamlesh Zota | Zota Health Care | 52 | |
Management Performance
| Return On Equity | 0.0472 | ||||
| Return On Asset | 0.0108 |
Aarey Drugs Pharmace Leadership Team
Elected by the shareholders, the Aarey Drugs' board of directors comprises two types of representatives: Aarey Drugs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aarey. The board's role is to monitor Aarey Drugs' management team and ensure that shareholders' interests are well served. Aarey Drugs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aarey Drugs' outside directors are responsible for providing unbiased perspectives on the board's policies.
| A Kathawala, Chief Accountant | ||
| Milind Churi, Head Production | ||
| Kailash Jethlia, Company Officer | ||
| Mihir BE, Chairman MD | ||
| Nimit Ghatalia, Executive Director | ||
| J Gohil, Head Plant | ||
| Preeti Rathi, Company Officer | ||
| Mira Ghatalia, Chief Officer | ||
| Maruti Ugade, Head Logistic |
Aarey Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aarey Drugs a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0472 | ||||
| Return On Asset | 0.0108 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 1.44 B | ||||
| Shares Outstanding | 28.35 M | ||||
| Shares Owned By Insiders | 50.49 % | ||||
| Shares Owned By Institutions | 2.34 % | ||||
| Price To Book | 0.79 X | ||||
| Price To Sales | 0.18 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Aarey Stock Analysis
When running Aarey Drugs' price analysis, check to measure Aarey Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarey Drugs is operating at the current time. Most of Aarey Drugs' value examination focuses on studying past and present price action to predict the probability of Aarey Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarey Drugs' price. Additionally, you may evaluate how the addition of Aarey Drugs to your portfolios can decrease your overall portfolio volatility.